Brind.

GSK and Boehringer Ingelheim are facing product liability claims regarding Zantac.

1 report, 1 independent Updated Jan 1

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

GSK Boehringer Ingelheim

Keep exploring

The entities involved

GSK
British multinational pharmaceutical and biotechnology company
- Clement Fourny joins Biodextris as CEO, a company that originated as a GSK development center.Mon 15:26
- GSK acquired Sierra Oncology.Mon 14:28
Boehringer Ingelheim
German pharmaceutical company
- Sheila Denton was appointed as General Counsel & Corporate Secretary at Boehringer Ingelheim.Mon 15:03
- Boehringer Ingelheim and Palatin Technologies reported $13.2 million in revenue from their Fiscal 2026 collaboration.Mon 13:31

Coverage

Newest first; wire copies grouped

Jan 1gsk.com